216 related articles for article (PubMed ID: 17434187)
1. Assessment of atypical DNA intercalating agents in biological and in silico systems.
Snyder RD
Mutat Res; 2007 Oct; 623(1-2):72-82. PubMed ID: 17434187
[TBL] [Abstract][Full Text] [Related]
2. The influence of N-dialkyl and other cationic substituents on DNA intercalation and genotoxicity.
Snyder RD; McNulty J; Zairov G; Ewing DE; Hendry LB
Mutat Res; 2005 Oct; 578(1-2):88-99. PubMed ID: 15990125
[TBL] [Abstract][Full Text] [Related]
3. Small molecule intercalation with double stranded DNA: implications for normal gene regulation and for predicting the biological efficacy and genotoxicity of drugs and other chemicals.
Hendry LB; Mahesh VB; Bransome ED; Ewing DE
Mutat Res; 2007 Oct; 623(1-2):53-71. PubMed ID: 17449065
[TBL] [Abstract][Full Text] [Related]
4. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DNA intercalation potential of pharmaceuticals and other chemicals by cell-based and three-dimensional computational approaches.
Snyder RD; Ewing DE; Hendry LB
Environ Mol Mutagen; 2004; 44(2):163-73. PubMed ID: 15278920
[TBL] [Abstract][Full Text] [Related]
6. Toward a greater appreciation of noncovalent chemical/DNA interactions: application of biological and computational approaches.
Snyder RD; Hendry LB
Environ Mol Mutagen; 2005; 45(2-3):100-5. PubMed ID: 15668940
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
Snyder RD; Gillies PJ
Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
[TBL] [Abstract][Full Text] [Related]
8. DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays.
Snyder RD; Ewing D; Hendry LB
Mutat Res; 2006 Oct; 609(1):47-59. PubMed ID: 16857419
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
[TBL] [Abstract][Full Text] [Related]
10. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
11. In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolites.
Pandey AK; Gurbani D; Bajpayee M; Parmar D; Ajmani S; Dhawan A
Mutat Res; 2009 Feb; 661(1-2):57-70. PubMed ID: 19059273
[TBL] [Abstract][Full Text] [Related]
12. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
13. Noncovalent interactions with DNA: an overview.
Strekowski L; Wilson B
Mutat Res; 2007 Oct; 623(1-2):3-13. PubMed ID: 17445837
[TBL] [Abstract][Full Text] [Related]
14. On the molecular mechanism of drug intercalation into DNA: a simulation study of the intercalation pathway, free energy, and DNA structural changes.
Mukherjee A; Lavery R; Bagchi B; Hynes JT
J Am Chem Soc; 2008 Jul; 130(30):9747-55. PubMed ID: 18611009
[TBL] [Abstract][Full Text] [Related]
15. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of non-covalent interactions: DNA intercalators.
Ferguson LR; Denny WA
Mutat Res; 2007 Oct; 623(1-2):14-23. PubMed ID: 17498749
[TBL] [Abstract][Full Text] [Related]
17. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.
Palchaudhuri R; Hergenrother PJ
Curr Opin Biotechnol; 2007 Dec; 18(6):497-503. PubMed ID: 17988854
[TBL] [Abstract][Full Text] [Related]
18. Studying non-covalent drug-DNA interactions.
Rehman SU; Sarwar T; Husain MA; Ishqi HM; Tabish M
Arch Biochem Biophys; 2015 Jun; 576():49-60. PubMed ID: 25951786
[TBL] [Abstract][Full Text] [Related]
19. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
